Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
SHACU Stock Summary
In the News
SCP & CO Healthcare Acquisition Company Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 15, 2021
TAMPA, Fla., March 11, 2021 /PRNewswire/ -- SCP & CO Healthcare Acquisition Company (NASDAQ: SHACU) (the "Company") announced that, commencing March 15, 2021, holders of the units sold in the Company's initial public offering may elect to separately trade shares of the Company's Class A common stock and warrants included in the units.
U.S. IPO Weekly Recap: The IPO Market Has No Time To RLX In A 6-IPO Week
The 2021 IPO market continued gaining momentum this past week as six IPOs and 14 SPACs raised $6.2 billion. The IPO pipeline remained active as well, with 36 new filings from IPOs and SPACs combined.
SHACU Financial details
SHACU Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2020-12-31 | 2021-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | 0 | 0.7 | |
Operating cash flow per share | 0 | -0.06 | |
Free cash flow per share | 0 | -0.06 | |
Cash per share | 0 | 8.53 | |
Book value per share | 0 | 7.84 | |
Tangible book value per share | 0 | 7.84 | |
Share holders equity per share | 0 | 7.84 | |
Interest debt per share | 0.01 | 0 | |
Market cap | 278.59M | 265.76M | |
Enterprise value | 278.71M | 264.52M | |
P/E ratio | 0 | 13.96 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | 0 | -161.27 | |
PFCF ratio | 0 | -161.27 | |
P/B Ratio | 12.09K | 1.25 | |
PTB ratio | 12.09K | 1.25 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | 0 | 29.83 | |
EV to operating cash flow | 0 | -160.51 | |
EV to free cash flow | 0 | -160.51 | |
Earnings yield | 0 | 0.07 | |
Free cash flow yield | 0 | -0.01 | |
Debt to equity | 6.41 | 0 | |
Debt to assets | 0.7 | 0 | |
Net debt to EBITDA | 0 | -0.14 | |
Current ratio | 0.13 | 4.49 | |
Interest coverage | 0 | -13.26 | |
Income quality | 0 | -0.19 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 0 | 11.13 | |
ROIC | 0 | -0.01 | |
Return on tangible assets | 0 | 0.08 | |
Graham Net | -0.01 | 7.82 | |
Working capital | -162.29K | 1.48M | |
Tangible asset value | 23.05K | 212.75M | |
Net current asset value | -162.29K | -17.36M | |
Invested capital | 6.41 | 0 | |
Average receivables | 0 | 0 | |
Average payables | 0 | 0 | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 0 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 0 | |
Inventory turnover | 0 | 0 | |
ROE | 0 | 0.09 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0.18 | 0.02 | 0.47 | 0.08 | 0.04 | |
Operating cash flow per share | 0 | 0 | -0.01 | -0.01 | -0.01 | |
Free cash flow per share | 0 | 0 | -0.01 | -0.01 | -0.01 | |
Cash per share | 8.05 | 8.05 | 8.04 | 8.04 | 8.07 | |
Book value per share | 7.4 | 7.4 | 7.63 | 7.71 | 7.75 | |
Tangible book value per share | 7.4 | 7.4 | 7.63 | 7.71 | 7.75 | |
Share holders equity per share | 7.4 | 7.4 | 7.63 | 7.71 | 7.75 | |
Interest debt per share | 0 | 0 | 0 | 0.01 | 0.04 | |
Market cap | 279.74M | 281.75M | 281.18M | 282.61M | 283.76M | |
Enterprise value | 278.4M | 280.5M | 280.29M | 281.93M | 283.14M | |
P/E ratio | 13.84 | 105.94 | 5.15 | 30.73 | 61.97 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -2.68K | -3.24K | -771.41 | -1.41K | -1.13K | |
PFCF ratio | -2.68K | -3.24K | -771.41 | -1.41K | -1.13K | |
P/B Ratio | 1.31 | 1.32 | 1.28 | 1.27 | 1.27 | |
PTB ratio | 1.31 | 1.32 | 1.28 | 1.27 | 1.27 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 55.91 | 10.41K | 41.78 | 105.09 | 108.82 | |
EV to operating cash flow | -2.67K | -3.23K | -768.99 | -1.4K | -1.12K | |
EV to free cash flow | -2.67K | -3.23K | -768.99 | -1.4K | -1.12K | |
Earnings yield | 0.02 | 0 | 0.05 | 0.01 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.27 | -46.25 | -0.13 | -0.25 | -0.24 | |
Current ratio | 10.72 | 4.49 | 5.47 | 4.06 | 1.66 | |
Interest coverage | -23.97 | -15.44 | -4.18 | -0.98 | -0.33 | |
Income quality | -0.02 | 24.57 | -0.05 | -0.09 | -0.22 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.41 | 1.96 | 9.03 | 3.72 | 2.64 | |
ROIC | 0 | -0.01 | 0 | 0 | 0 | |
Return on tangible assets | 0.02 | 0 | 0.06 | 0.01 | 0 | |
Graham Net | 7.37 | 7.38 | 7.61 | 7.7 | 7.74 | |
Working capital | 1.95M | 1.48M | 1.18M | 800.96K | 348.08K | |
Tangible asset value | 212.75M | 212.75M | 219.38M | 221.68M | 222.83M | |
Net current asset value | -17.5M | -17.36M | -10.8M | -8.82M | -8.69M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.02 | 0 | 0.06 | 0.01 | 0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SHACU Frequently Asked Questions
What is SCP & CO Healthcare Acquisition Company stock symbol ?
SCP & CO Healthcare Acquisition Company is a US stock , located in Tampa of Fl and trading under the symbol SHACU
What is SCP & CO Healthcare Acquisition Company stock quote today ?
SCP & CO Healthcare Acquisition Company stock price is $10.05 today.
Is SCP & CO Healthcare Acquisition Company stock public?
Yes, SCP & CO Healthcare Acquisition Company is a publicly traded company.